120 related articles for article (PubMed ID: 3401595)
1. Immunophenotypic diagnosis of clinical and preclinical chronic lymphatic leukemia by using monoclonal antibodies against the cCLLa, a CLL-associated antigen.
Faguet GB; Agee JF
Blood; 1988 Aug; 72(2):679-84. PubMed ID: 3401595
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against the chronic lymphatic leukemia antigen cCLLa: characterization and reactivity.
Faguet GB; Agee JF
Blood; 1987 Aug; 70(2):437-43. PubMed ID: 2440501
[TBL] [Abstract][Full Text] [Related]
3. Common chronic lymphatic leukemia antigen (cCLLa); distribution, fate and clinical applications.
Faguet GB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):305-10. PubMed ID: 2464791
[TBL] [Abstract][Full Text] [Related]
4. An antigen common to chronic lymphocytic and hairy cell leukemia cells not shared by normal lymphocytes or by other leukemic cells.
Agee JF; Garver FA; Faguet GB
Blood; 1986 Jul; 68(1):62-8. PubMed ID: 2941085
[TBL] [Abstract][Full Text] [Related]
5. Blood kinetics, tissue distribution, and radioimaging of anti-common chronic lymphatic leukemia antigen (cCLLa) monoclonal antibody CLL2 in mice transplanted with cCLLa-bearing human leukemia cells.
Faguet GB; Agee JF; DiPiro JT
Blood; 1990 May; 75(9):1853-61. PubMed ID: 2331525
[TBL] [Abstract][Full Text] [Related]
6. Modulation, shedding, and serum titers of the chronic lymphatic leukemia-associated antigen: characterization and clinical correlations.
Faguet GB; Agee JF
Blood; 1989 Nov; 74(7):2493-500. PubMed ID: 2804376
[TBL] [Abstract][Full Text] [Related]
7. Four ricin chain A-based immunotoxins directed against the common chronic lymphocytic leukemia antigen: in vitro characterization.
Faguet GB; Agee JF
Blood; 1993 Jul; 82(2):536-43. PubMed ID: 7687163
[TBL] [Abstract][Full Text] [Related]
8. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: assessment of LD50 and MTD of four ricin-based anti-cCLLa immunotoxins (ITs) in Balb/c mice.
Faguet GB; Agee JF
Leuk Lymphoma; 1997 May; 25(5-6):531-7. PubMed ID: 9250824
[TBL] [Abstract][Full Text] [Related]
9. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.
Faguet GB; Agee JF
Leuk Lymphoma; 1997 May; 25(5-6):509-20. PubMed ID: 9250822
[TBL] [Abstract][Full Text] [Related]
10. Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.
Brown VA; Smith SK; Dewar AE; Stockdill G; Maddy AH
Clin Exp Immunol; 1985 Oct; 62(1):95-103. PubMed ID: 3877584
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
12. A subpopulation of lymph node B-CLL cells expresses the common acute lymphoblastic leukemia antigen.
Van den Oord JJ; De Wolf-Peeters C; Tricot G; Desmet VJ
Anticancer Res; 1984; 4(6):379-82. PubMed ID: 6240222
[TBL] [Abstract][Full Text] [Related]
13. Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.
Velardi A; Prchal JT; Prasthofer EF; Grossi CE
Blood; 1985 Jan; 65(1):149-55. PubMed ID: 3155487
[TBL] [Abstract][Full Text] [Related]
14. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS).
Garcia C; Rosén A; Kimby E; Aguilar-Santelises M; Jondal M; Bjorkholm M; Holm G; Mellstedt H
Leuk Res; 1989; 13(1):31-7. PubMed ID: 2536870
[TBL] [Abstract][Full Text] [Related]
15. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies.
Herrmann F; Dörken B; Ludwig WD; Schwarting R
Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
Robak T
Leuk Lymphoma; 2004 Feb; 45(2):205-19. PubMed ID: 15101704
[TBL] [Abstract][Full Text] [Related]
17. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
Tefferi A; Li CY; Phyliky RL
Mayo Clin Proc; 1988 Aug; 63(8):801-6. PubMed ID: 2456433
[TBL] [Abstract][Full Text] [Related]
18. Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells.
Ligler FS; Schlam ML; Curley R; Brodsky I; Benzel JE
Am J Hematol; 1983 Dec; 15(4):335-42. PubMed ID: 6196965
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia progenitor cells carry the antigens T65, BA-1, and Ia.
Perri RT; Royston I; LeBien TW; Kay NE
Blood; 1983 May; 61(5):871-5. PubMed ID: 6600949
[TBL] [Abstract][Full Text] [Related]
20. Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).
Kimby E; Axelsson B; Björkholm M; Gordon J; Holm G; Mellstedt H
Med Oncol Tumor Pharmacother; 1985; 2(4):261-7. PubMed ID: 2935687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
